Improving the use of intravenous antihypertensive medications in the hospital setting: a quality improvement initiative for patient safety

Intravenous (IV) hydralazine, enalapril and labetalol are oftentimes used without indication for the treatment of asymptomatic hypertension in the hospital setting and have been shown to have substantial adverse effects that are associated with increased morbidity and mortality, as well as longer le...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Open Qual
Autors principals: Salman, Jacob, Salman, Alicja, Kumar, Sarwan, Gjeka, Rudin, Tegeltija, Vesna, Peterson, Daymon, Chams, Nour, Ross, Ian
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2019
Matèries:
Quality Improvement Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6887509/
https://ncbi.nlm.nih.gov/pubmed/31803850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjoq-2019-000626
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars